Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 2
2010 1
2011 4
2012 4
2013 3
2014 2
2015 1
2016 3
2017 6
2018 2
2019 4
2020 10
2021 7
2022 6
2023 4
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Results by year

Filters applied: . Clear all
Page 1
Correction: Combined TP53 status in tumor-free resection margins and circulating microRNA profiling predicts the risk of locoregional recurrence in head and neck cancer.
Ganci F, Allegretti M, Frascolla C, Spinella F, Rollo F, Sacconi A, De Pascale V, Palcau AC, Manciocco V, Vescovo M, Cotroneo E, Blandino F, Benevolo M, Covello R, Muti P, Strano S, Vidiri A, Fontemaggi G, Pellini R, Blandino G. Ganci F, et al. Among authors: rollo f. Biomark Res. 2024 Mar 26;12(1):37. doi: 10.1186/s40364-024-00582-0. Biomark Res. 2024. PMID: 38532476 Free PMC article. No abstract available.
Interobserver agreement in the interpretation of anal cytology.
Benevolo M, Rollo F, Latini A, Giuliani M, Giglio A, Giuliani E, Donà MG. Benevolo M, et al. Among authors: rollo f. Cancer Cytopathol. 2024 Mar 7. doi: 10.1002/cncy.22807. Online ahead of print. Cancer Cytopathol. 2024. PMID: 38451011
Combined TP53 status in tumor-free resection margins and circulating microRNA profiling predicts the risk of locoregional recurrence in head and neck cancer.
Ganci F, Allegretti M, Frascolla C, Spinella F, Rollo F, Sacconi A, Valentina P, Palcau AC, Manciocco V, Vescovo M, Cotroneo E, Blandino F, Benevolo M, Covello R, Muti P, Strano S, Vidiri A, Fontemaggi G, Pellini R, Blandino G. Ganci F, et al. Among authors: rollo f. Biomark Res. 2024 Mar 5;12(1):32. doi: 10.1186/s40364-024-00576-y. Biomark Res. 2024. PMID: 38444004 Free PMC article.
HSF-1/miR-145-5p transcriptional axis enhances hyperthermic intraperitoneal chemotherapy efficacy on peritoneal ovarian carcinosis.
Di Agostino S, Canu V, Donzelli S, Pulito C, Sacconi A, Ganci F, Valenti F, Goeman F, Scalera S, Rollo F, Bagnato A, Diodoro MG, Vizza E, Carosi M, Rufini B, Federici O, Giofrè M, Carboni F, Muti P, Ciliberto G, Strano S, Valle M, Blandino G. Di Agostino S, et al. Among authors: rollo f. Cell Death Dis. 2023 Aug 19;14(8):535. doi: 10.1038/s41419-023-06064-9. Cell Death Dis. 2023. PMID: 37598177 Free PMC article.
The Glioma-IRE project - Molecular profiling in patients with glioma: steps toward an individualized diagnostic and therapeutic approach.
Villani V, Casini B, Tanzilli A, Lecce M, Rasile F, Telera S, Pace A, Piludu F, Terrenato I, Rollo F, De Nicola F, Fanciulli M, Pallocca M, Ciliberto G, Carosi M. Villani V, et al. Among authors: rollo f. J Transl Med. 2023 Mar 23;21(1):215. doi: 10.1186/s12967-023-04057-y. J Transl Med. 2023. PMID: 36959606 Free PMC article.
A Real-World Systematic Analysis of Driver Mutations' Prevalence in Early- and Advanced-Stage NSCLC: Implications for Targeted Therapies in the Adjuvant Setting.
Terrenato I, Ercolani C, Di Benedetto A, Gallo E, Melucci E, Casini B, Rollo F, Palange A, Visca P, Pescarmona E, Melis E, Gallina F, Sacconi A, Cecere FL, Landi L, Cappuzzo F, Ciliberto G, Buglioni S. Terrenato I, et al. Among authors: rollo f. Cancers (Basel). 2022 Jun 16;14(12):2971. doi: 10.3390/cancers14122971. Cancers (Basel). 2022. PMID: 35740637 Free PMC article.
55 results